-+ 0.00%
-+ 0.00%
-+ 0.00%

BMO Capital Maintains Outperform on Merck & Co, Raises Price Target to $142

Benzinga·07/13/2026 12:58:43
語音播報
BMO Capital analyst Evan David Seigerman maintains Merck & Co (NYSE:MRK) with a Outperform and raises the price target from $135 to $142.